Kalaris Therapeutics, Inc. (KLRS): 8-K filed Jul 17, 2026

Form type

8-K

Filing date

Jul 17, 2026

Accession number

0001193125-26-306737

Filer

Kalaris Therapeutics, Inc. (CIK 1754068)